Search Results - "Löfberg, Mervi"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Complete remission of central nervous system manifestations of IgG4-related disease with rituximab – a case report by Sihvonen, Aleksi J., Laakso, Sini M., Tynninen, Olli, Saaren-Seppälä, Heikki, Löfberg, Mervi

    “…IgG4-related disease (IgG4-RD) is an emerging immune-mediated chronic fibrotic disease characterized by tumour-like mass formation. Reports of brain…”
    Get full text
    Journal Article
  2. 2

    Screening for late-onset Pompe disease in Finland by Palmio, Johanna, Auranen, Mari, Kiuru-Enari, Sari, Löfberg, Mervi, Bodamer, Olaf, Udd, Bjarne

    Published in Neuromuscular disorders : NMD (01-11-2014)
    “…Highlights • We screened 108 myopathy patients for late-onset Pompe disease in Finland. • The screening did not reveal new Pompe patients. • Pompe disease is…”
    Get full text
    Journal Article
  3. 3

    A novel mutation of the GAA gene in a Finnish late‐onset pompe disease patient: Clinical phenotype and follow‐up with enzyme replacement therapy by Korpela, Mari P., Paetau, Anders, Löfberg, Mervi I., Timonen, Marjut H., Lamminen, Antti E., Kiuru‐Enari, Sari M.K.

    Published in Muscle & nerve (01-07-2009)
    “…Pompe disease is a rare, progressive disease leading to skeletal muscle weakness due to deficiency of the acid α‐glucosidase (GAA) enzyme. Herein we report the…”
    Get full text
    Journal Article
  4. 4

    Molecular characterization of McArdle’s disease in two large Finnish families by Bruno, Claudio, Löfberg, Mervi, Tamburino, Lucia, Jänkälä, Heidi, Hadjigeorgiou, George M, Andreu, Antonio L, Shanske, Sara, Somer, Hannu, DiMauro, Salvatore

    Published in Journal of the neurological sciences (01-06-1999)
    “…We have studied two large unrelated Finnish families with myophosphorylase deficiency (McArdle’s disease). In one, we identified a new nonsense mutation at…”
    Get full text
    Journal Article
  5. 5

    Decreased Aerobic Capacity in ANO5-Muscular Dystrophy by Ylikallio, Emil, Auranen, Mari, Mahjneh, Ibrahim, Lamminen, Antti, Kousi, Maria, Träskelin, Ann-Liz, Muurinen, Tiina, Löfberg, Mervi, Salmi, Tapani, Paetau, Anders, Lehesjoki, Anna-Elina, Piirilä, Päivi, Kiuru-Enari, Sari

    Published in Journal of neuromuscular diseases (29-11-2016)
    “…Anoctaminopathies are muscle diseases caused by recessive mutations in the ANO5 gene. The effects of anoctaminopathy on oxidative capacity have not previously…”
    Get more information
    Journal Article
  6. 6

    Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy by Argov, Zohar, Löfberg, Mervi, Arnold, Douglas L.

    Published in Muscle & nerve (01-09-2000)
    “…Phosphorus magnetic resonance spectroscopy (P‐MRS) has now been used in the investigation of muscle energy metabolism in health and disease for over 15 years…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Abnormal blood lactate accumulation after exercise in patients with multiple mitochondrial DNA deletions and minor muscular symptoms by Lindholm, Harri, Löfberg, Mervi, Somer, Hannu, Näveri, Hannu, Sovijärvi, Anssi

    Published in Clinical physiology and functional imaging (01-03-2004)
    “…Summary Study objectives:  Muscle is one of the most commonly affected organs in mitochondrial disorders, and the symptoms are often exercise related. The…”
    Get full text
    Journal Article
  9. 9

    ATP, phosphocreatine and lactate in exercising muscle in mitochondrial disease and McArdle’s disease by Löfberg, Mervi, Lindholm, Harri, Näveri, Hannu, Majander, Anna, Suomalainen, Anu, Paetau, Anders, Sovijärvi, Anssi, Härkönen, Matti, Somer, Hannu

    Published in Neuromuscular disorders : NMD (01-05-2001)
    “…We studied exercise-induced changes in the adenosine triphosphate (ATP), phosphocreatine (PCr), and lactate levels in the skeletal muscle of mitochondrial…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Serum gelsolin and rhabdomyolysis by Löfberg, Mervi, Paunio, Tiina, Tähtelä, Riitta, Kiuru, Sari, Somer, Hannu

    Published in Journal of the neurological sciences (07-05-1998)
    “…We measured the serum gelsolin, actin-modulating protein, levels in five patients after rhabdomyolysis. We observed a tendency of serum gelsolin (83 kDa) to…”
    Get full text
    Journal Article
  12. 12

    Antimyosin scintigraphy compared with magnetic resonance imaging in inflammatory myopathies by Löfberg, M, Liewendahl, K, Lamminen, A, Korhola, O, Somer, H

    Published in Archives of neurology (Chicago) (01-07-1998)
    “…To compare indium In 111 altumomab pentetate-labeled antimyosin scintigraphy with magnetic resonance imaging (MRI) in the diagnosis and follow-up of patients…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Myosin heavy-chain fragments and cardiac troponins in the serum in rhabdomyolysis. Diagnostic specificity of new biochemical markers by Löfberg, M, Tähtelä, R, Härkönen, M, Somer, H

    Published in Archives of neurology (Chicago) (01-12-1995)
    “…Myosin is the major structural protein in muscle. Antibodies to beta-type heavy meromyosin react with cardiac and slow-twitch skeletal muscle. Cardiac TnT and…”
    Get more information
    Journal Article